Literature DB >> 7104158

Antihypertensive drugs and blood lipids: the Oslo study.

P Leren, I Eide, O P Foss, A Helgeland, I Hjermann, I Holme, S E Kjeldsen, P G Lund-Larsen.   

Abstract

1 The report presents the effects on blood lipids and uric acid of six different antihypertensive drugs, used alone and of five different combinations of two antihypertensive drugs. 2 Prazosin significantly lowered serum LDL + VLDL cholesterol and total triglycerides. Atenolol lowered LDL + VLDL cholesterol to a smaller but significant extent. Both pindolol and hydrochlorothiazide (HCTH) were without effect, while oxprenolol significantly increased total triglycerides. Propranolol significantly lowered HDL cholesterol and increased total triglycerides and uric acid. 3 The combination prazosin and pindolol had a favourable effect on the lipid profile, while the combination propranolol and HCTH lowered HDL cholesterol but increased total triglycerides. Propranolol and prazosin lowered HDL cholesterol, while methyldopa and HCTH, and HCTH and amiloride were without effect on blood lipids. 4 It is suggested that the metabolic effects of antihypertensive drugs could be of special importance in long-term treatment of mild hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104158      PMCID: PMC1402145          DOI: 10.1111/j.1365-2125.1982.tb01954.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Metabolic effects of beta-adrenoreceptor blockers.

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

Authors:  A Helgeland; I Hjermann; P Leren; S Enger; I Holme
Journal:  Br Med J       Date:  1978-08-05

3.  Effect of chronic administration of propranolol on lipoprotein composition.

Authors:  N Tanaka; S Sakaguchi; K Oshige; T Niimura; T Kanehisa
Journal:  Metabolism       Date:  1976-10       Impact factor: 8.694

4.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

5.  Effects of diuretics on plasma lipoproteins in healthy men.

Authors:  C Joos; H Kewitz; D Reinhold-Kourniati
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

6.  Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

Authors:  A Helgeland; I Hjermann; I Holme; P Leren
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

7.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13

8.  Elevation of serum lipid levels during diuretic therapy of hypertension.

Authors:  R P Ames; P Hill
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

9.  The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man.

Authors:  J D England; L A Simons; J C Gibson; M Carlton
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 May-Jun       Impact factor: 2.557

10.  Effect of propranolol and prazosin on blood lipids. The Oslo Study.

Authors:  P Leren; P O Foss; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen
Journal:  Lancet       Date:  1980-07-05       Impact factor: 79.321

View more
  10 in total

1.  Dose-titration study of alfuzosin, a new alpha 1-adrenoceptor blocker, in essential hypertension.

Authors:  S Leto di Priolo; P Priore; G Cocco; C Sfrisi; J L Cazor
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Effect of pindolol on changes in serum lipids induced by hydrochlorthiazide.

Authors:  G Frithz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Which beta blocker?

Authors:  A Breckenridge
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

Review 4.  Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.

Authors:  Ajibola Monsur Adedayo; Oladipupo Olafiranye; David Smith; Alethea Hill; Ferdinand Zizi; Clinton Brown; Girardin Jean-Louis
Journal:  Sleep Breath       Date:  2012-08-18       Impact factor: 2.816

Review 5.  [Antihypertensive therapy and lipid metabolism].

Authors:  W Krone; D Müller-Wieland; H Greten
Journal:  Klin Wochenschr       Date:  1984-03-01

6.  Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.

Authors:  M Välimäki; L Maass; K Harno; E A Nikkilä
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Influence of two beta-adrenoceptor antagonists, propranolol and pindolol, on cold adaptation in the rat.

Authors:  M L Kortelainen; P Huttunen; T Lapinlampi
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

Review 8.  Clinical use of beta-adrenoceptor blockade in systemic hypertension.

Authors:  J Nadelmann; W H Frishman
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

9.  Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep.

Authors:  Andras Bikov; Zsofia Lazar; Peter Horvath; David Laszlo Tarnoki; Adam Domonkos Tarnoki; Luca Fesus; Marton Horvath; Martina Meszaros; Gyorgy Losonczy; Laszlo Kunos
Journal:  Lung       Date:  2019-02-02       Impact factor: 2.584

Review 10.  Hypertension and Dyslipidemia Combined Therapeutic Approaches.

Authors:  Claudio Borghi; Federica Fogacci; Davide Agnoletti; Arrigo F G Cicero
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.